A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris

PHASE3CompletedINTERVENTIONAL
Enrollment

1,399

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

August 31, 2007

Conditions
Acne Vulgaris
Interventions
DRUG

IDP-110

Topical application for 12 weeks

DRUG

Clindamycin

Topical application for 12 weeks

DRUG

Benzoyl peroxide

Topical application for 12 weeks

DRUG

Vehicle

Topical application for 12 weeks

Trial Locations (33)

10021

Office of Fran E. Cook-Bolden, MD, New York

11203

SUNY Downstate Medical Center, Brooklyn

11234

Atlantic Dermatologic Associates, LLP, Brooklyn

11790

DermResearch Center of New York, Stony Brook

14609

Helendale Dermatology and Medical Spa, Rochester

14623

Dermatology Associates of Rochester, Rochester

17033

Milton S. Hershey Medical Center, Hershey

19707

Webster Dermatology, PA, Hockessin

23507

Virginia Clinical Research, Inc, Norfolk

24501

Education & Research Foundation, Lynchburg

30078

Gwinnett Clinical Research Center, Inc., Snellville

30263

MedaPhase Inc., Newnan

30904

Derm Center of Augusta, Augusta

32174

Advanced Dermatology and Cosmetic Surgery, Ormond Beach

32204

North Florida Dermatology Associates, PA, Jacksonville

33401

Florida Dermatology Institute, West Palm Beach

33486

Skin Care Research, Inc., Boca Raton

33781

Dermatology Research, Pinellas Park

34711

Advanced Dermatology and Cosmetic Surgery, Clermont

40202

Dermatology Specialists Research, Louisville

46617

South Bend Clinic, South Bend

47714

Hudson Dermatology, Evansville

48038

Michigan Center for Research Corp., Clinton Township

53719

Madison Skin & Research, Inc., Madison

55432

Minnesota Clinical Study Center, Fridley

60563

DuPage Medical Group, Naperville

71913

Burke Pharmaceutical Research, Hot Springs

73069

Central Sooner Research, Norman

75006

Thomas J. Stephens & Associates, Carrollton

75246

Dallas Associated Dermatologists, Dallas

77802

J & S Studies, Inc., Bryan

78759

DermResearch, Inc., Austin

06511

The Savin Center, PC, New Haven

Sponsors
All Listed Sponsors
lead

Dow Pharmaceutical Sciences

INDUSTRY